Viewing Study NCT06278051


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2025-12-28 @ 10:34 PM
Study NCT ID: NCT06278051
Status: COMPLETED
Last Update Posted: 2024-12-05
First Post: 2024-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module